SARAFLOXACIN

SynDRA canonical compound SYN0002075 — structure-anchored drug synonym record

Clinical phase	Launched
Mechanism of action	bacterial DNA gyrase inhibitor
Indication	gram-negative bacterial infections \| gram-positive bacterial infections
Disease area	infectious disease

Mechanisms of action (all sources)

Sarafloxacine
Sarafloxacino
ABBOTT-57135
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
Difloxacino
Difloxacinum
Sarafloxacinum
Sarafloxacin [INN:BAN]
Quinolone der.
3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
RC3WJ907XY
Abbott 57135
Saraflox
Sarafloxacin (INN)
SARAFLOXACIN [INN]
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
Difloxacine [French]
Difloxacinum [Latin]
Difloxacino [Spanish]
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
Sarafloxacine [INN-French]
Sarafloxacinum [INN-Latin]
Sarafloxacino [INN-Spanish]
Sarafloxacin hydrochloride trihydrate
HSDB 7035
UNII-RC3WJ907XY
6-Fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
CCRIS 8500
SR-05000002002
Spectrum2_000036
Spectrum3_001953
SARAFLOXACIN [MI]
SARAFLOXACIN [HSDB]
BSPBio_003553
MLS006011798
CHEMBL37858
SCHEMBL311593
SPBio_000131